Misinterpretation of TPMT by a DTC Genetic Testing CompanyBROWNSTEIN, C. A; MARGULIES, D. M; MANZI, S. F et al.Clinical pharmacology and therapeutics. 2014, Vol 95, Num 6, pp 598-600, issn 0009-9236, 3 p.Article

Les tests génétiques grand public en « caméra cachée » = An undercover investigation of DTC testingJORDAN, Bertrand.MS. Médecine sciences. 2011, Vol 27, Num 1, pp 103-106, issn 0767-0974, 4 p.Article

Protection des signatures moléculaires et des tests multigéniques: soyons créatifsCHARPENTIER, Aurélie; CHAJMOWICZ, Marion.Biofutur (Puteaux). 2012, Num 337, pp 58-59, issn 0294-3506, 2 p.Article

Un test d'ADN fécal pour le dépistage du cancer colorectalThe Medical letter on drugs and therapeutics (Edition française). 2014, Vol 36, Num 23, pp 115-116, issn 0253-8512, 2 p.Article

A Cross-Sectional Study of Attitudes About the Use of Genetic Testing for Clinical Care Among Patients with an Alcohol Use DisorderSTROBEL, Brittany; MCMANUS, Lauren; LEONG, Shirley et al.Alcohol and alcoholism (Oxford). 2013, Vol 48, Num 6, pp 700-703, issn 0735-0414, 4 p.Article

The Cost Effectiveness of Genetic Testing for CYP2C19 Variants to Guide Thienopyridine Treatment in Patients with Acute Coronary Syndromes: A New Zealand EvaluationPANATTONI, Laura; BROWN, Paul M; TE AO, Braden et al.PharmacoEconomics (Auckland). 2012, Vol 30, Num 11, pp 1067-1084, issn 1170-7690, 18 p.Article

Psychiatrie de liaison et conseil génétique. Discussion = Liaison psychiatry and genetic testing. DiscussionLAHLOU-LAFORET, K; ALLILAIRE, J.-F; LAXENAIRE, M et al.Annales médico-psychologiques. 2010, Vol 168, Num 3, pp 224-227, issn 0003-4487, 4 p.Conference Paper

Genetic Techniques for Pharmacogenetic AnalysesVAN DER STRAATEN, Tahar; VAN SCHAIK, Ron H. N.Current pharmaceutical design (Print). 2010, Vol 16, Num 2, pp 231-237, issn 1381-6128, 7 p.Article

Quand demander un avis génétique ? = When to refer to genetic consultation?MICHOU, Laëtitia.Revue du rhumatisme monographies (Print). 2010, Vol 77, Num 4, pp 352-359, issn 1878-6227, 8 p.Article

Gene patents and genetic testing in the United StatesKLEIN, Roger D.Nature biotechnology (Print). 2007, Vol 25, Num 9, pp 989-991, issn 1087-0156, 3 p.Article

Le dépistage néonatal généralisé par des tests d'analyse biologique = Generalized neonatal screening based on laboratory testsARDAILLOU, Raymond; LE GALL, Jean-Yves.Bulletin de l'Académie nationale de médecine. 2006, Vol 190, Num 8, pp 1745-1759, issn 0001-4079, 15 p.Article

Single cell gel/comet assay : Guidelines for in vitro and in vivo genetic toxicology testingTICE, R. R; AGURELL, E; ANDERSON, D et al.Environmental and molecular mutagenesis (Print). 2000, Vol 35, Num 3, pp 206-221, issn 0893-6692Conference Paper

L'Amérique face à l'information génétique : L'irrésistible envolée des tests génétiques = America faces genetic information : Genetic tests take flightDEROIN, P.Biofutur (Puteaux). 1998, Num 181, pp 24-27, issn 0294-3506Article

Une fiction collective se met en place pour assurer l'acceptabilité sociale des tests génétiques : L'irrésistible envolée des tests génétiques = Social acceptability of genetic tests : Genetic tests take flightDIANOUX, L; KLARSFELD, A.Biofutur (Puteaux). 1998, Num 181, issn 0294-3506, p. 34Article

The ethical implications of the human genome project for the workplaceBRADY, T.The International journal of applied philosophy. 1995, Vol 10, Num 1, pp 47-56, issn 0739-098XArticle

Cost-effectiveness analysis of UGT1A1 genetic testing to inform antiretroviral prescribing in HIV diseaseSCHACKMAN, Bruce R; HAAS, David W; BECKER, Jessica E et al.Antiviral therapy (London). 2013, Vol 18, Num 3, pp 399-408, issn 1359-6535, 10 p.Article

Ethical issues of genetic susceptibility testing for occupational diseases: opinions of trainees in a high-risk jobVISSER, M. J; RHEBERGEN, M. D. F; KEZIC, S et al.International archives of occupational and environmental health. 2013, Vol 86, Num 7, pp 827-836, issn 0340-0131, 10 p.Article

The Development and Validation of a Decision-Analytic Model Representing the Full Disease Course of Acute Myeloid LeukemiaLEUNIS, Annemieke; KEN REDEKOP, W; VAN MONTFORT, Kees A. G. M et al.PharmacoEconomics (Auckland). 2013, Vol 31, Num 7, pp 605-621, issn 1170-7690, 17 p.Article

ASPETTI ETICI E FILOSOFICI DEL DNAMARTINI, Alessandra; NAPOLEONI, Francesca; PANTANO, Flaminia et al.Bio-ethos. 2013, Num 17, pp 36-58, issn 1972-6341, 23 p.Article

Cost-Effectiveness Model of Use of Genetic Testing as an Aid in Assessing the Likely Benefit of Aspirin Therapy for Primary Prevention of Cardiovascular DiseaseSHIFFMAN, Dov; SLAWSKY, Katherine; FUSFELD, Lauren et al.Clinical therapeutics. 2012, Vol 34, Num 6, pp 1387-1394, issn 0149-2918, 8 p.Article

Double heterozygosity for mutations in BRCA1 and BRCA2 in German breast cancer patients: implications on test strategies and clinical managementHEIDEMANN, Simone; FISCHER, Christine; JONAT, Waiter et al.Breast cancer research and treatment. 2012, Vol 134, Num 3, pp 1229-1239, issn 0167-6806, 11 p.Article

Evaluation of RAD51C as cancer susceptibility gene in a large breast-ovarian cancer patient population referred for genetic testingDE LEENEER, K; VAN BOCKSTAL, M; VAN ASPEREN, C. J et al.Breast cancer research and treatment. 2012, Vol 133, Num 1, pp 393-398, issn 0167-6806, 6 p.Article

Ethical and Social Issues in Pharmacogenomics TestingVIJVERBERG, S. J. H; PIETERS, T; CORNEL, M. C et al.Current pharmaceutical design (Print). 2010, Vol 16, Num 2, pp 245-252, issn 1381-6128, 8 p.Article

Approaches to the Patient with Neurogenetic DiseaseBIRD, Thomas D.Clinics in laboratory medicine. 2010, Vol 30, Num 4, issn 0272-2712, vii, 785-793 [10 p.]Article

Approccio bioetico e biogiuridico al counseling genetico per malattia di Alzheimer = Bioethical and biojuridical approach to the genetic counselling for Alzheimer's diseaseGAROFALO, Lorella; MELE, Vincenza.Medicina e morale. 2001, Vol 51, Num 1, pp 41-59, issn 0025-7834Article